Professional Marketing briefs

Following an agreement signed in Q3, Pfizer's US sales reps are deploying Callidus Software Inc.'s iCentera Sales Enablement SaaS platform to improve internal sales, contract sales and channel partners.   

Sucampo Pharma Americas, Inc., wholly owned subsidiary of Sucampo Pharmaceuticals, has named Greg Deener VP, marketing, strategy & implementation. He will oversee marketing functions related to Sucampo's approved drugs and play a key role in developing global marketing strategies.

Pharma and healthcare market research firm Manhattan Research has expanded its custom research capabilities for marketing topics, patient groups, physician specialties and geographic regions.

Physicians Proviso (P2), a national private physicians' network, has launched out of the New Orleans area. Now active in 15 states, including New York, Texas and California, the network plans to expand outreach throughout the country.

Marken, a worldwide support provider of clinical research logistics, has launched a global brand and advertising campaign focusing on its unique position in the pharma industry.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.